P

Pharmakon Advisors, LP

10 employees

Pharmakon Advisors is a New York-based investment company that offers financing solutions to commercial stage, biotechnology companies.

Investor insights

Sectors invested in

Biotechnology12

Medical6

Health Care6

Pharmaceutical6

Therapeutics4

Life Science2

Clinical Trials2

ADCs1

Regulatory Affairs1

Clinical Development1

Drug Discovery1

Rare Diseases1

Product Commercialization1

Concussion1

Wellness1

Neurological Biomarkers1

mTBI1

Diagnosis & Prognosis1

Neurocognitive Testing1

Point of Care1

Funding rounds participated in

$125M sweet spot round size

Most of their 13 investments are in rounds between $75M and $250M

Investor type

Venture Debt

Basic info

Industry

investment management

Sectors

Date founded

2009

Investments made

B

BioCryst Pharmaceuticals, Inc. raised $450M on April 17, 2023

Investors: Pharmakon Advisors, LP

I

ImmunoGen, Inc. raised $75M on April 6, 2023

Investors: Pharmakon Advisors, LP

I

Insmed Incorporated raised $500M on October 19, 2022

Investors: Pharmakon Advisors, LP

U

UroGen Pharma raised $100M on March 8, 2022

Investors: Pharmakon Advisors, LP

C

Coherus BioSciences raised $100M on January 7, 2022

Investors: Pharmakon Advisors, LP

E

Evolus raised $125M on December 14, 2021

Investors: Pharmakon Advisors, LP

B

BRAINBox Solutions, Inc. raised $23M on December 8, 2020

Investors: TAUBER FAMILY FOUNDATION, VTC Innovation Fund, Genoa Ventures, Astia, BioVentures Investors, Chainstay Capital & Advisors and Pharmakon Advisors, LP

O

OptiNose raised $150M on September 12, 2020

Investors: Pharmakon Advisors, LP

S

Sarepta Therapeutics raised $250M on December 13, 2019

Investors: Pharmakon Advisors, LP

U

Undisclosed raised $100M on November 12, 2019

Investors: Pharmakon Advisors, LP

FAQ